Loren Rafeson is Partner, Growth Equity Partners, at BDC Capital where he helps leading Canadian companies scale nationally and internationally, as well as execute ownership transitions. Since joining BDC in 2018, Loren has been involved in the execution of BDC’s investments in Firmex, Groupe Tecnic, Monarch House, Preciseley Microtechnology, and Resolute Health. He currently serves on the boards of Groupe Tecnic, Monarch House, and Resolute Health and previously served on the boards of Firmex, InvestorCOM, and Neighbourly Pharmacy (TSX:NBLY, formerly Rx Drug Mart).

Loren has over 15 years’ experience in private equity and corporate finance having worked for several investment management firms in Canada and the United Kingdom, as well as the merchant bank and the investment bank of two Canadian financial institutions. Loren holds a BBA from the Schulich School of Business at York University and an MBA from INSEAD. In addition, he is a CFA charterholder.